GLTO insider filings
Galecto, Inc. — 46 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-02-12. Screen GLTO transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for GLTO between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Galecto, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-12 | 4 | Bruno Julianne — Director | Option exercise (M): 129,000 @ $0 · Option exercise (M): 129 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Fairmount Funds Management LLC — Director, 10% owner Fairmount Healthcare Fund II L.P. — 10% owner Fairmount Healthcare Co-Invest V L.P. — 10% owner Kiselak Tomas — 10% owner Harwin Peter Evan — Director, 10% owner | Option exercise (M): 5,809,000 @ $0 · Option exercise (M): 2,904,000 @ $0 · Option exercise (M): 5,809 (derivative) @ $0 · Option exercise (M): 2,904 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Sattarzadeh Sherwin — Chief Operating Officer | Grant/award (A): 190,376 @ $0 · Grant/award (A): 444,209 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Hewes L. Becker — Chief Medical Officer | Grant/award (A): 264,629 @ $0 · Grant/award (A): 528,603 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Schambye Hans T. — Chief Executive Officer, Director | Option exercise (M): 1,360 · Sale (S): 700 @ $21.38 · Option exercise (M): 1,360 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Winslow Garrett — General Counsel | Option exercise (M): 680 · Sale (S): 255 @ $21.38 · Option exercise (M): 680 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Firmani Lori — Chief Financial Officer | Option exercise (M): 374 · Sale (S): 135 @ $21.41 · Option exercise (M): 374 (derivative) @ $0 | EDGAR |
| 2025-07-08 | 4 | Schambye Hans T. — Chief Executive Officer, Director | Option exercise (M): 1,360 · Sale (S): 735 @ $3.38 · Option exercise (M): 1,360 (derivative) @ $0 | EDGAR |
| 2025-07-08 | 4 | Winslow Garrett — General Counsel | Option exercise (M): 680 · Sale (S): 260 @ $3.39 · Option exercise (M): 680 (derivative) @ $0 | EDGAR |
| 2025-07-08 | 4 | Firmani Lori — Interim CFO | Option exercise (M): 374 · Sale (S): 147 @ $3.39 · Option exercise (M): 374 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Prener Anne — Director | Grant/award (A): 720 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | WECHSLER AMY B — Director | Grant/award (A): 720 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Dallas Jayson Donald Alexander — Director | Grant/award (A): 720 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Munshi Amit — Director | Grant/award (A): 720 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Shapiro David — Director | Grant/award (A): 720 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | GOLDFISCHER CARL — Director | Grant/award (A): 1,440 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Winslow Garrett — General Counsel | Option exercise (M): 1,320 · Sale (S): 471 @ $5.60 · Option exercise (M): 1,320 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Firmani Lori — Interim CFO | Option exercise (M): 726 · Sale (S): 261 @ $5.63 · Option exercise (M): 726 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Kronmiller Matthew — EVP Strategy and CBO | Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Schambye Hans T. — Chief Executive Officer, Director | Option exercise (M): 2,640 · Sale (S): 1,341 @ $5.60 · Option exercise (M): 2,640 (derivative) @ $0 · Grant/award (A): 16,400 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | WECHSLER AMY B — Director | Grant/award (A): 720 (derivative) @ $0 · Grant/award (A): 480 (derivative) @ $0 | EDGAR |
| 2024-10-11 | 4 | Winslow Garrett — General Counsel | Grant/award (A): 15,600 (derivative) @ $0 | EDGAR |
| 2024-10-11 | 4 | Kronmiller Matthew — EVP Strategy and CBO | Grant/award (A): 8,600 (derivative) @ $0 | EDGAR |
| 2024-10-11 | 4 | Firmani Lori — Interim CFO | Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2024-10-11 | 4 | Schambye Hans T. — Chief Executive Officer, Director | Grant/award (A): 44,100 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Prener Anne — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Dallas Jayson Donald Alexander — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Munshi Amit — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Shapiro David — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | GOLDFISCHER CARL — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Schambye Hans T. — Chief Executive Officer, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Winslow Garrett — General Counsel | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Freve Jonathan — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-08-17 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Genesis GP LLC — 10% owner OrbiMed Israel GP II, L.P. — 10% owner OrbiMed Advisors Israel II Ltd — 10% owner OrbiMed Capital GP VII LLC — 10% owner | Sale (S): 38,327 @ $0.75 · Sale (S): 248,819 @ $0.75 · Sale (S): 535,534 @ $0.75 | EDGAR |
| 2023-08-02 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Genesis GP LLC — 10% owner OrbiMed Israel GP II, L.P. — 10% owner OrbiMed Advisors Israel II Ltd — 10% owner OrbiMed Capital GP VII LLC — 10% owner | Sale (S): 26,622 @ $3 · Sale (S): 29,700 @ $3 · Sale (S): 153,078 @ $3 | EDGAR |
| 2023-07-27 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Genesis GP LLC — 10% owner OrbiMed Israel GP II, L.P. — 10% owner OrbiMed Advisors Israel II Ltd — 10% owner OrbiMed Capital GP VII LLC — 10% owner | Sale (S): 7,800 @ $2.92 · Sale (S): 4,700 @ $2.92 · Sale (S): 26,700 @ $2.92 | EDGAR |
| 2023-07-17 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Genesis GP LLC — 10% owner OrbiMed Israel GP II, L.P. — 10% owner OrbiMed Advisors Israel II Ltd — 10% owner OrbiMed Capital GP VII LLC — 10% owner | Sale (S): 9,800 @ $2.40 · Sale (S): 52,800 @ $2.40 · Sale (S): 132,100 @ $2.40 | EDGAR |
| 2023-06-15 | 4 | Prener Anne — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Dallas Jayson Donald Alexander — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Munshi Amit — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Khuong Chau Quang — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Shapiro David — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | GOLDFISCHER CARL — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2023-04-17 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Genesis GP LLC — 10% owner OrbiMed Israel GP II, L.P. — 10% owner OrbiMed Advisors Israel II Ltd — 10% owner OrbiMed Capital GP VII LLC — 10% owner | Sale (S): 703 @ $1.82 · Sale (S): 3,784 @ $1.82 · Sale (S): 9,459 @ $1.82 · Sale (S): 2,091 @ $1.86 · Sale (S): 11,245 @ $1.86 · Sale (S): 28,110 @ $1.86 · +3 more | EDGAR |
| 2023-04-12 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Genesis GP LLC — 10% owner OrbiMed Israel GP II, L.P. — 10% owner OrbiMed Advisors Israel II Ltd — 10% owner OrbiMed Capital GP VII LLC — 10% owner | Sale (S): 2,584 @ $1.79 · Sale (S): 13,899 @ $1.79 · Sale (S): 34,745 @ $1.79 · Sale (S): 703 @ $1.82 · Sale (S): 3,784 @ $1.82 · Sale (S): 9,459 @ $1.82 · +3 more | EDGAR |
| 2023-04-07 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Genesis GP LLC — 10% owner OrbiMed Israel GP II, L.P. — 10% owner OrbiMed Advisors Israel II Ltd — 10% owner OrbiMed Capital GP VII LLC — 10% owner | Sale (S): 4,687 @ $2.18 · Sale (S): 25,220 @ $2.18 · Sale (S): 63,058 @ $2.18 · Sale (S): 487 @ $2 · Sale (S): 2,620 @ $2 · Sale (S): 6,558 @ $2 | EDGAR |
Recent 8-K events — Galecto, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 2.02 — Results of Operations and Financial Condition 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-06 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GLTO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →